James B Froehlich MD MPH
Preventive Cardiology, Vascular Medicine
Melvin A. Lester, M.D. Professor of Cardiovascular Medicine Professor of Internal Medicine; Director, Vascular Medicine; University of Michigan Medical School
Join to View Full Profile
Frankel Cardiovascular Center1500 E Medical Center Dr. SPC 5853Ann Arbor, MI 48109
Phone+1 734-615-4907
Fax+1 734-232-4132
Dr. Froehlich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Harvard School of Public HealthMPH, Epidemilology and Clinical Study Design, 1999 - 2001
University of MichiganFellowship, Cardiovascular Disease, 1993 - 1996
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1989 - 1993
UMass Chan Medical SchoolResidency, Surgery, 1986 - 1989
Geisel School of Medicine at DartmouthClass of 1986
Dartmouth CollegeAB, Government, 1978 - 1982
Certifications & Licensure
MI State Medical License 1993 - 2027
MA State Medical License 1989 - 2007
CT State Medical License 2004 - 2005
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis Start of enrollment: 2009 Nov 01
Publications & Presentations
PubMed
- Outcomes of Oral Anticoagulation with Concomitant NSAID Use: A Registry Based Cohort Study.Nelish Ardeshna, Josh Errickson, Xiaowen Kong, Mona A Ali, Naina Chipalkatti
The American Journal of Medicine. 2025-12-01 - 1 citationsAn Intervention to Reduce Antiplatelet Use without Gastroprotection in Patients Using Warfarin: The AEGIS Cluster Randomized Trial.Jacob E Kurlander, Danielle Helminski, Xueting Tao, Sameer D Saini, Sarah L Krein
Thrombosis and Haemostasis. 2025-08-01 - 2 citationsA Comparison of Outcomes With Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous Thromboembolism.Jordan K Schaefer, Josh Errickson, Xiaowen Kong, Mona A Ali, Naina Chipalkatti
JACC. Advances. 2025-05-01
Abstracts/Posters
- Impact of Adding Aspirin to Direct Oral Anticoagulant Therapy without an Apparent IndicationJames B Froehlich, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- A Multi-Center Quality Improvement Intervention to Reduce the Inappropriate Use of Aspirin Among Patients Anticoagulated with Warfarin for Atrial Fibrillation or Venou...James B Froehlich, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Reducing Dose of Popular Blood Thinners May Limit Risk of Future BleedingDecember 18th, 2024- Taking Aspirin Could Be Doing More Harm Than GoodOctober 28th, 2022
- Hearing Is HealingSeptember 3rd, 2022
- Join now to see all
Professional Memberships
- Member
- Society for Vascular MedicinePresident
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
